Generic Industry’s Perspective on the New GMP Initiative - PowerPoint PPT Presentation

selma
generic industry s perspective on the new gmp initiative n.
Skip this Video
Loading SlideShow in 5 Seconds..
Generic Industry’s Perspective on the New GMP Initiative PowerPoint Presentation
Download Presentation
Generic Industry’s Perspective on the New GMP Initiative

play fullscreen
1 / 6
Download Presentation
Generic Industry’s Perspective on the New GMP Initiative
94 Views
Download Presentation

Generic Industry’s Perspective on the New GMP Initiative

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Generic Industry’s Perspective on the New GMP Initiative May 21, 2003 Generic Pharmaceutical Association Kenneth Lavin, M.Sc. Director, Regulatory ComplianceTEVA Pharmaceuticals USA

  2. Risk-Based Approach • Definition • Implementation • Benefits • Dialogue • Guidance

  3. Changes to Approved Applications • Interim Specifications • Development Report: • Guidelines • How to be used • No Negative Impact on Review • Goals

  4. Pre-Approval Inspections • No longer universally necessary • Except Novel Compounds & New Technologies • Chemistry Reviewer Inspections • No Delays

  5. Communications • 483 Dispute Resolution • Publish Internal FDA polices and Procedures • Publish Control Documents • Proceduralize Pre-ANDA meetings

  6. Summary – Guidance & Procedures • GPhA welcomes the opportunity to work with FDA, industry and academia on developing the science to create the procedures to allow for a new regulatory framework.